Latest It Compliance News

Anson Resources has confirmed its Bosydaba#1 well can supply brine at 6,000 barrels per day, meeting the flow requirements for its planned lithium extraction demonstration plant in Utah. This milestone reduces costs and accelerates project timelines.

Emu NL has lodged a formal review application against the Takeovers Panel's recent variation of orders, signaling continued regulatory tension in its takeover proceedings.

ASX has revealed it expects to incur an additional $25 million to $35 million in operating expenses in FY26 due to the ongoing ASIC compliance inquiry. Despite this, the company remains committed to its five-year strategy focused on technology and risk management.

SRJ Technologies clarifies its financial position and strategic rationale behind a recent capital raise and acquisition of a UAE entity, addressing ASX concerns over its viability and voluntary suspension.

AMP Limited reported a modest increase in underlying net profit after tax to $236 million for the first half of 2025, supported by steady revenues and disciplined cost management across its key business units.

AMP Limited has announced an ordinary dividend of AUD 0.02 per share for the six months ending June 2025, with a 20% franking credit, payable in late September.

Prophecy International and Complexica announce a strategic merger to form MergeCo, an ASX-listed AI pure play with enhanced scale, product synergies, and growth potential.

SportsHero Limited has responded to ASX queries about recent unusual trading activity, confirming no undisclosed price-sensitive information and ongoing compliance with disclosure rules.

Key Petroleum has completed a $152,361 placement, issuing over 3.6 million shares to a sophisticated investor to support merger preparations and working capital needs.

Silk Logistics Holdings has secured court approval for its acquisition by DP World Australia, with shares set to be suspended on the ASX and a cash payout scheduled for shareholders.

Lowell Resources Fund (ASX – LRT) has announced a 12-month on-market unit buy-back of up to 10% of its units, aiming to boost unitholder returns and capital efficiency without compromising future growth.

Rhythm Biosciences has responded to an ASX price query following a sudden surge in its share price and trading volume, confirming no undisclosed information is driving the activity.